B.Riley Financial analyst William Wood has reiterated their bullish stance on IMUX stock, giving a Buy rating on September 16. William Wood ...

Systemic sclerosis is an autoimmune disease that primarily causes inflammation of the skin, as well as internal organs such ...

Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a ...

As usual, a second trial will be needed before UCB and Biogen can file dapirolizumab pegol with regulators. It will be called ...

Zenas BioPharma, which is developing immunology-based therapies, said on Friday it is targeting a valuation of as much as ...

[10] Conti P, Kempuraj D. Important role of mast cells in multiple sclerosis. Mult Scler Relat Disord. 2016;5:77-80. [11] Skaper SD, Facci L, Giusti P. Mast cells, glia and neuroinflammation: partners ...

Biogen markets several multiple sclerosis drugs including Plegridy ... Biogen has several drug candidates in phase 3 trials ...

“If not treated early upon diagnosis, multiple sclerosis can lead to significant ... senior vice president and head of clinical development, Immunology, Cardiovascular and Neuroscience, Bristol Myers ...

The WHO recently concluded that there is no level of alcohol consumption that is safe for our health. Evidence strongly ...

Today is an important day for Cardarelli as it inaugurates a department dedicated to patients with multiple sclerosis. We ...

Contineum Therapeutics, Inc. (Nasdaq: CTNM), a clinical stage biopharmaceutical company focused on discovering and developing ...

NORTHAMPTON, MA / ACCESSWIRE / September 12, 2024 / With people at the heart of our mission, Viatris is committed to ...